Insulet Corp. (PODD)
133.21
-4.02
(-2.93%)
USD |
NASDAQ |
Nov 20, 16:00
135.00
+1.79
(+1.34%)
After-Hours: 19:36
Insulet Gross Profit (TTM) : 2.326B for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.326B |
| June 30, 2026 | 2.204B |
| March 31, 2026 | 2.078B |
| December 31, 2025 | 1.954B |
| September 30, 2025 | 1.819B |
| June 30, 2025 | 1.686B |
| March 31, 2025 | 1.564B |
| December 31, 2024 | 1.46B |
| September 30, 2024 | 1.389B |
| June 30, 2024 | 1.303B |
| March 31, 2024 | 1.231B |
| December 31, 2023 | 1.160B |
| September 30, 2023 | 1.012B |
| June 30, 2023 | 902.20M |
| March 31, 2023 | 828.60M |
| December 31, 2022 | 798.40M |
| September 30, 2022 | 794.40M |
| June 30, 2022 | 795.10M |
| March 31, 2022 | 787.40M |
| December 31, 2021 | 745.30M |
| September 30, 2021 | 682.10M |
| June 30, 2021 | 649.20M |
| March 31, 2021 | 610.10M |
| December 31, 2020 | 570.40M |
| September 30, 2020 | 555.40M |
| Date | Value |
|---|---|
| June 30, 2020 | 523.58M |
| March 31, 2020 | 497.60M |
| December 31, 2019 | 477.59M |
| September 30, 2019 | 454.11M |
| June 30, 2019 | 433.20M |
| March 31, 2019 | 399.05M |
| December 31, 2018 | 368.37M |
| September 30, 2018 | 340.67M |
| June 30, 2018 | 314.01M |
| March 31, 2018 | 297.81M |
| December 31, 2017 | 282.95M |
| September 30, 2017 | 261.68M |
| June 30, 2017 | 243.56M |
| March 31, 2017 | 229.56M |
| December 31, 2016 | 213.05M |
| September 30, 2016 | 197.53M |
| June 30, 2016 | 173.99M |
| March 31, 2016 | 156.90M |
| December 31, 2015 | 145.65M |
| September 30, 2015 | 137.00M |
| June 30, 2015 | 141.90M |
| March 31, 2015 | 143.29M |
| December 31, 2014 | 143.29M |
| September 30, 2014 | 138.53M |
| June 30, 2014 | 126.79M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Boston Scientific Corp. | 13.82B |
| Abbott Laboratories | 25.24B |
| TransMedics Group, Inc. | 415.68M |
| The Cooper Cos., Inc. | 2.601B |
| Stryker Corp. | 16.62B |